Microbial Bioburden on Oral Solid Dosage Forms

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-02-02-2002, Volume 26, Issue 2

Low levels of some microorganisms that are present in oral solid dosage forms are unlikely to present a risk to patients. The amount of water activity in these products can help determine when microbiological testing should be conducted.

Related Content:

Solid/Semi-Solid DosageManufacturingDosage FormsManufacturing, Solid Dosage DrugsManufacturing, Drug ProductsPharmaceutical Technology-02-02-2002
How New Regulations Are Impacting Pharmaceutical Manufacturing Facility Design
A Look at the Impact of Industry Trends on Sensor Technologies (INTERPHEX 2024)
Single-Use Technologies Reinforce Fluid-Handling Workflows (INTERPHEX 2024)